The Group is focused on delivering to shareholders, over the medium to longer term, value growth and profitability through commercialisation of its intellectual property.
The Directors believe that the Affimer affinity reagent platform provides the greatest potential for such value growth by delivering a partnered pipeline of Affimer drugs and building a profitable research and diagnstics reagents business through licensing. The Group is therefore focusing its investments primarily on its proprietary Affimer technology.
The Group also provides diagnostic tools and services for veterinarians through its Animal Health business including specialisms in allergy, acute phase proteins and cancer.
Country of Registration & Operation
The Company is Registered in England and Wales (Registration number 04748597) and the main country of operation is the UK.
Registered office – Unit 20, Ash Way, Thorp Arch Estate, Wetherby LS23 7FA.
Current significant shareholders are as follows:
IP Group plc – 24.58%
Lombard Odier Asset Management – 8.99%
Ruffer LLP – 7.00%
J O Hambro - 6.70%
Baillie Gifford & Co Limited – 6.18%
Fidelity - 5.89%
NFU - 3.46%
As at 15th June 2018 the company has 68,989,487 ordinary shares of 10p each in issue.
31.0% of the ordinary shares of the Company are not held in public hands.
Avacta Group has not applied or agreed to have any of its securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.
There are no restrictions on the transfer of Avacta Group plc’s AIM securities.
Avacta Group plc is subject to the UK City Code on Takeovers and Mergers.
This information was last updated on 15th June 2018.
Joint broker and Nomad – finnCap Limited, 60 New Broad Street, London EC2M 1JJ
Joint broker – WG Partners, 85 Gresham Street, London, EC2V 7NQ
Auditor – KPMG LLP, 1 Sovereign Square, Sovereign Street, Leeds, LS1 4DA
Solicitor – Walker Morris, Kings Court, 12 King Street, Leeds, LS1 2HL
Registrar – Link Market Services Limited, Bourne House, 34 Beckenham Road, Beckenham, BR3 4TU. www.signalshares.com.
Investor and Media Relations – Yellow Jersey PR, 1st floor, 30 Stamford Street, London, SE1 9LQ. www.yellowjerseypr.com